Home / Drug shortages / Adalimumab-ryvk Kit

Adalimumab-ryvk Kit — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Adalimumab-ryvk Kit from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 11/13/2025.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
51759-523-21
Dosage Form
Presentation
Simlandi, Kit, Kit (NDC 51759-523-21)
Initial Posting
11/13/2025
Revised Date

FDA data resources